Winship Cancer Institute, Emory University — Atlanta, Georgia

Winship Cancer Institute, Emory University is a clinical research site located in Atlanta, Georgia, United States 30322-1013.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Winship Cancer Institute, Emory University has participated in 110 clinical trials with 44 currently active.

Therapeutic areas: Relapsed and/or Refractory Multiple Myeloma (RRMM), Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic.

Sponsors: Takeda, Regeneron Pharmaceuticals, OncoPep, Inc..

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Winship Cancer Institute, Emory University?

Winship Cancer Institute, Emory University has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Winship Cancer Institute, Emory University conducted?

Winship Cancer Institute, Emory University has 110 clinical trials on record, with 44 currently active. Their work covers Relapsed and/or Refractory Multiple Myeloma (RRMM), Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic.

Is Winship Cancer Institute, Emory University accredited by Crixeo Health?

Yes — Winship Cancer Institute, Emory University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Winship Cancer Institute, Emory University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.